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Abstract A new type of DNA-intercalating viologen dications, 
derived from the N,N'-dialkyl-6-(2-pyridyl)phenanthridine struc- 
ture (in which dialkyl is -CH2CH2-, -CH2CH2CH2-, or (-CH3)2, 
abbreviated dq2pyp, dq3pyp, andMe2pyp, respectively), are able 
to produce frank strand breaks in supercoiled plasmid DNA upon 
irradiation with visible light. The amount of photocleavage is 
similar for the three drugs. The observed DNA photosensitization 
appears to follow a single-strand cleavage model, as shown by a 
kinetic analysis of the reaction with dq2pyp. The photodynamic 
action of the drugs seems to be initiated by a light-induced elec- 
tron transfer reaction from the nucleobases, given the singlet 
excited-state redox potentials (ca. + 2.1 V vs. SHE) and the low 
quantum yields of singlet molecular oxygen production of the 
drugs (0.1-0.2 in aerated D20). 
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Photoinduced electron transfer 
reaction of I o  2 with guanine; (b) direct or OH'-mediated hy- 
drogen abstraction from the deoxyribose moiety; (c) oxidation 
of guanine by the photoexcited rug. It is not uncommon to 
find the simultaneous participation of two of such processes in 
the sensitized photooxidation of nucleosides [4]. 
In a recent paper [5], we have reported the intercalative 
interaction with DNA of a novel family of photoactive organic 
compounds, namely dialkylated 6-(2-pyridyl)phenanthridine 
(pyp) viologens (Scheme 1). The possibility of photochemistry 
with DNA was then suggested, based on their singlet excited 
state redox potentials and the efficient fluorescence quenching 
observed with GMP and AMP (kq = 1.2 x 10 l° and 6.8 x l09 
M ~. s ], respectively). The goal of the present paper is to report 
the capability of dq2pyp, dq3pyp, and Me2pyp, to photosen- 
sitize DNA cleavage, as well as to obtain evidences about the 
possible mechanism responsible for their photodynamic 
activity. 
1. Introduction 
There is a growing interest in the rational design of novel 
small molecules able to react with nucleic acids and/or to probe 
their rich polymorphism, in order to improve the armory of 
molecular tools for detecting and manipulating the genetic ma- 
terial [1]. Photocleavage of nucleic acids is a valuable property 
of DNA-targeted rugs, since it allows to use light as a trigger 
of the nuclease activity. By attaching the drug to an appropriate 
oligonucleotide, sequence-selective photonucleases can be cre- 
ated, directed to both single-stranded or double-stranded nu- 
cleic acids [2]. Photosensitization f DNA by drugs may be 
clinically useful as well; i.e. photoaddition ofpsoralens to DNA 
is used to treat psoriasis and other skin diseases. 
Chemically different compounds have been reported to pho- 
tocleave DNA/transition-metal coordination compounds (e.g. 
1,10-phenanthroline derivatives of Ru(II), Rh(III) or Co(III)), 
polycyclic heteroaromatic dyes (such as riboflavin, rose bengal 
or ethidium), and ketones (acetophenone, benzophenone) [3]. 
Three main mechanisms have been proposed to explain such 
an activity [3]: (a) singlet oxygen (IO2) generation by energy 
transfer from a drug triplet to 02, followed by subsequent dark 
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Abbreviations: dq2pyp, 6,7-dihydro-pyrido[2',l':3,4]pyrazino[1,2-f]phe- 
nanthridinediium dibromide dihydrate; dq3pyp, 7,8-dihydro-6H- 
pyrido[2', 1': 3,4][ 1,4]diazepino[1,2-J]phenanthridinediium dibromide 
hydrate; Me2pyp, 6-(1-methylpyridine)-5-methylphenanthridinediium 
dichloride hemihydrate; JO2, singlet molecular oxygen. 
2. Materials and methods 
2.1. Materials 
Supercoiled pBR322 plasmid DNA was purchased from New Eng- 
land Biolabs. Calf thymus DNA was isolated inour laboratory follow- 
ing the procedure of Kay et al. [6], and further treated with RNAse, 
pronase, and proteinase K in order to thoroughly eliminate contami- 
nating RNA and proteins. The three drugs were prepared in our labo- 
ratory, and their synthesis will be described elsewhere (Orellana et al., 
to be published). Molecular weight marker X, EcoRI, catalase and 
superoxide dismutase, were from Boehringer-Mannheim. Sodium azide 
was from Aldrich. All the experiments were conducted in 'P' buffer (10 
mM sodium phosphate, pH 5.5). 
2.2. Photosensitized cl avage of pBR322 plasmid DNA 
Samples for irradiation (15 ~tl, in Eppendorf tubes) contained P
buffer and variable amounts of plasmid and drugs. Irradiation was 
made via a 6.5-mm diameter fused-silica fiber optics (Fiberguide Ind.) 
fitted to the tube, that delivered >360 nm light from an Oriel 150-W 
Xe lamp provided with IR and cut-off ilters. After exposure to light, 
2/ll of loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol, 
40% sucrose) were added to the reaction mixtures. All the samples were 
<)-< 
~ +  N( + R = (CH2)2 (dq2pyp) 
R R = (CH2)3 (dq3pyp) 
R = CH3, CH3 (Me2pyp) 
Scheme 1. 
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analyzed by 1% agarose gel electrophoresis in Tris-acetate (TAE) 
buffer, followed by 30 min of ethidium bromide staining (1 mg/ml). 
Once electrophoresed, all the stained gels were photographed on an UV 
transilluminator using a Polaroid camera with an orange filter. The film 
negatives (Polaroid 665) were scanned with a Molecular Dynamics 
Model 325S densitometer and the spots were integrated using the 
Image- Quant software. In order to compare different lanes of the same 
or different gels, a normalization procedure was adopted: the intensity 
of each spot was divided by the sum of the intensities of all spots in the 
same lane. The lesser intercalation of ethidium into supercoiled DNA 
(form I) was taken into account by dividing the corresponding intensity 
by 0.8 [7]. The plasmid used throughout showed a dimeric form (D) in 
the agarose gels, which appeared as the slowest spot in each lane. As 
cleavage proceeded, the amount of dimer decreased and eventually 
disappeared before any linearized form (III) was formed. This fact 
indicates a direct transformation D~I I  (nicked form), which must be 
taken into account when quantifying the cleavage. Thus, the photo- 
cleavage extent (in the absence of form III) was defined as [II]/ 
([I] + [II] + [D]). 
2.4. Photobleaching studies 
Samples (1 ml, in quartz cuvettes) containing P buffer, dq2pyp 
(2 × 10 -5 M) and, when required, calf thymus DNA (5 × 10 -4 M base 
pairs), were irradiated for different times using the same conditions as 
in the photocleavage experiments but removing the optical fiber. Ab- 
sorption spectra were recorded between irradiations, in order to detect 
light-induced chemical changes in the drugs. 
2.5. Determination of the quantum yield of singlet oxygen production 
(~lo2) 
The steady-state ~O2 luminescence at 1270 nm was used to quantify 
the yield of LO: formation in air-equilibrated samples of dq2pyp and 
dq3pyp in D20 (Euriso-top, > 99.8% D), using the spectroscopic system 
described before [8]. The estimated error of the measurements is 3%. 
Rose bengal in D20 ((i~lo: = 0.75 [9]) was used as reference sensitizer. 
3. Results and discussion 
Fig. 1A depicts the photocleavage of supercoiled pBR322 
plasmid by the three investigated viologens, dq2pyp, dq3pyp 
and Me2pyp. When the plasmid is irradiated in the presence of 
the drugs, the intensity of the nicked form band (II) increases, 
whereas that of both form I and the dimeric form (D) substan- 
tially decreases. Under the conditions used, only single strand 
breaks are produced (see the control lane 2 of plasmid linear- 
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Fig. 1. (A) Photocleavage of DNA by 6-(2-pyridinium)phenan- 
thridinium viologens. Plasmid DNA (pBR322, 6.94 x 10 -5 M in bp) 
irradiated in the absence/presence of dq2pyp, dq3pyp, and Me2pyp (10 
,uM). Lane 1 = molecular weight marker X (Boehringer-Mannheim); 
lane 2 = pBR322 linearized with EcoRI; lane 3 = pBR322 in the dark; 
lane 4 = pBR322 irradiated for 90 min; lanes 5-7 = pBR322 + dq2pyp, 
dq3pyp, and Me2pyp, respectively, in the dark; lanes 8-10 = 
pBR322 + dq2pyp, dq3pyp, and Me2pyp, irradiated for 30, 40 and 90 
min, respectively. Key: I = supercoiled DNA; II = relaxed plasmid; 
III = linearized plasmid; D = plasmid dimer. (B) Linearization of 
pBR322 by photocleavage with dq2pyp. In these conditions (pBR322 
4 x 10 -5 M, dq2pyp 33 pM, 30 min of irradiation) both I and D forms 
have disappeared, and forms II and III have been produced. 
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Fig. 2. Plot of the intensities for forms I + D, II and III vs. dq2pyp 
concentration upon irradiation for 30 rain in P buffer. The fits corre- 
spond to the single-strand cleavage model of Kishikawa et al. [10], 
resulting in kl__+l I = 1600 M -1 .min -l and kn~ll  I = 65 M -1 .rain -1. Inset: 
evolution of form I intensities with time before any form II1 has been 
produced, for dq2pyp (a) 3,3/.tM, and (b) 13.3/.tM, fitted to a single- 
exponential function. The3~H~ values obtained from the fit are (a) 1100 
M -~. rain -~ and (b) 2000/M -~. min -1, very similar to that estimated from 
the plot of intensiti~/4s, drug concentration. 
{ 
ized by EcoP~).Given the experimental error, a quantification 
/ 
of the photoreaction extent with the three drugs under the 
conditions of reported in Fig. 1A yields similar amounts of 
cleavage: 42%, 42%, and 59% for dq2pyp, dq3pyp and Me2pyp, 
respectively. It should be stressed that the irradiation time of 
each drug in the presence of plasmid was inversely proportional 
to the area under their corresponding absorption spectra at 
wavelengths > 360 nm [5]. When the irradiation times and drug 
concentrations are the same, the photodynamic activity is in the 
order: dq2pyp > dq3pyp > Me2pyp; thus, all the kinetic and 
mechanistic experiments described below were conducted with 
dq2pyp. A similar amount of cleavage is to be expected if the 
photosensitization results from a base oxidation process, since 
the redox potential of the singlet excite state of the three drugs 
is similar, and (as in the conditions of the experiment) if the 
three DNA saturations are also similar. 
Illumination of dq2pyp intercalated into an excess of calf 
thymus DNA shows no spectral changes in the visible region 
of the drug up to 4 h. On the contrary, in the absence of DNA 
there is a small amount of drug photobleaching, probably due 
to light-activated nucleophilic attack by the solvent or the phos- 
phate groups. It appears that DNA protects the intercalated 
drug against photodegradation; i deed, molecular modeling [5] 
showed that the pyridinium moiety (the most susceptible to 
such an attack) contacts the wall of the DNA minor groove, 
avoiding the access of nucleophilic agents. Additionally, the 
spectral constancy also indicates that no photoadducts form 
between dq2pyp and DNA.  
Since form III was evident only at relatively long irradiation 
times and/or high sensitizer concentrations (Fig. 1B), the ab- 
sence of an independent pathway for double-strand cleavage is 
proposed: linearization would be produced by accumulation of 
single strand breaks at close positions in the opposite strands. 
In order to confirm this point, a coupled kinetic analysis of the 
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cleavage by dq2pyp was conducted, using the model and equa- 
tions put forward by Kishikawa et al. [10]. Fig. 2 reflects the 
amount of cleavage as a function of both drug concentration 
and time, together with the best fi s of the single-strand cleav- 
age model [10] to the experimental data. From the analysis, a 
k>~]l/kn_,ni ratio of kinetic constants of about 25 results, indi- 
cating that linearization occurs more probably by accumulation 
of single-strand breaks. Moreover, attempts to fit a double- 
strand cleavage model [10] to the experimental data resulted in 
unacceptable r sults. Thus, dq2pyp seems to photocleave DNA 
essentially by producing randomly distributed single-strand 
breaks. 
The involvement of diffusible oxygen species in the DNA 
photosensitization mechanism was also investigated by irradi- 
ating the dq2pyp/plasmid samples in the presence of 10 -3 M 
sodium azide (an efficient singlet oxygen quencher), superoxide 
dismutase (SOD, catalyst of the 205" + 2H +--) H20 2 + 02 reac- 
tion), catalase (catalyst of the H202--* HzO + ½02 reaction), and 
a mixture of SOD and catalase. Except with catalase alone, 
where no changes are detected, in all the cases a slight decrease 
of the cleavage was observed. SOD (with and without catalase) 
showed the largest inhibition, although it was constant even at 
enzyme concentrations upto 3.5 mg/ml, suggesting a secondary 
role of 02'  in the photocleavage mechanism. The smaller effect 
of sodium azide also points out a minor involvement of singlet 
oxygen; this interpretation is further supported by the meas- 
ured low quantum yields of 10 2 formation in D20:0.22 and 0.10 
for dq2pyp and dq3pyp, respectively. Moreover, an even lower 
production of ~O2 is expected when the drug is intercalated into 
DNA, since molecular oxygen would have a lesser access to it 
[11]. 
Taking into account he redox potential of *,he singlet excited 
state of the three drugs (+ 2.1 V vs. SHE [5]) and those of the 
DNA bases (-1.05, -1.15, -1.25, and -1.40 vs. SHE, for gua- 
nine, adenine, thymine and cytosine, respectively [12]), a photo- 
induced electron transfer from the DNA bases (preferably gua- 
nine) to the excited drug is thermodynamically feasible. The 
occurrence of such a charge transfer has been demonstrated 
indeed recently using laser flash photolysis and spectroelectro- 
chemical measurements [13], and is responsible for the previ- 
ously observed quenching of the drug fluorescence by mononu- 
cleotides and DNA. The oxidized base would then evolve 
towards a break in the sugar-phosphate backbone in one of the 
ways previously described [4]. This is not without precedent: it 
has been found that the singlet excited state of methylene blue 
(E *÷f° -- + 1.8 vs. SHE) is efficiently quenched in GC rich (but 
not in AT rich) regions of DNA to yield photosensitization, 
although a ~O2 mechanism cannot be ruled out [1 l]. This might 
be also the case of the photocleaving viologen MDAP 2+ (N,N'- 
dimethyl-2,7-diazapyrenium dication), which has been pro- 
posed to photooxydize DNA [14]; other authors claim, how- 
ever, that its photonuclease activity is due exclusively to ~O2 
generation [15]. 
Future experiments will aim to study the photocleavage of
different nucleic acid structures (triple helices, single-strands, 
hairpins, etc.), in order to investigate the structural specificity 
of these novel artificial photonucleases. 
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